Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Non-Current Deffered Revenue (2020 - 2025)

Cellebrite DI has reported Non-Current Deffered Revenue over the past 6 years, most recently at $49.5 million for Q4 2025.

  • Quarterly results put Non-Current Deffered Revenue at $49.5 million for Q4 2025, up 9.46% from a year ago — trailing twelve months through Dec 2025 was $49.5 million (up 9.46% YoY), and the annual figure for FY2025 was $49.5 million, up 9.46%.
  • Non-Current Deffered Revenue for Q4 2025 was $49.5 million at Cellebrite DI, up from $45.2 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for CLBT hit a ceiling of $49.5 million in Q4 2025 and a floor of $36.4 million in Q4 2021.
  • Median Non-Current Deffered Revenue over the past 5 years was $45.2 million (2024), compared with a mean of $44.1 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: increased 15.78% in 2022 and later fell 3.93% in 2024.
  • Cellebrite DI's Non-Current Deffered Revenue stood at $36.4 million in 2021, then rose by 15.78% to $42.2 million in 2022, then grew by 11.68% to $47.1 million in 2023, then decreased by 3.93% to $45.2 million in 2024, then rose by 9.46% to $49.5 million in 2025.
  • The last three reported values for Non-Current Deffered Revenue were $49.5 million (Q4 2025), $45.2 million (Q4 2024), and $47.1 million (Q4 2023) per Business Quant data.